31 related articles for article (PubMed ID: 1988655)
1. 5-hydroxytryptamine has an endothelium-derived hyperpolarizing factor-like effect on coronary flow in isolated rat hearts.
Chien CC; Su MJ
J Biomed Sci; 2015 Jun; 22(1):42. PubMed ID: 26076928
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin-induced constriction of the isolated rat occipital artery is segment dependent.
Chelko SP; Schmiedt CW; Lewis TH; Lewis SJ; Robertson TP
J Vasc Res; 2013; 50(6):478-85. PubMed ID: 24192548
[TBL] [Abstract][Full Text] [Related]
3. Serotonin and blood pressure regulation.
Watts SW; Morrison SF; Davis RP; Barman SM
Pharmacol Rev; 2012 Apr; 64(2):359-88. PubMed ID: 22407614
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
Foy RA; Myles JL; Wilkerson RD
J Pharmacol Exp Ther; 1992 May; 261(2):601-6. PubMed ID: 1533667
[TBL] [Abstract][Full Text] [Related]
5. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
6. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
[TBL] [Abstract][Full Text] [Related]
9. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
Lai FM; Tanikella T; Cervoni P
J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 5-hydroxytryptamine receptors in the cranial vasculature.
Saxena PR; Bom AH; Verdouw PD
Cephalalgia; 1989; 9 Suppl 9():15-22. PubMed ID: 2661012
[TBL] [Abstract][Full Text] [Related]
11. Vascular receptors for 5-hydroxytryptamine: distribution, function and classification.
Martin GR
Pharmacol Ther; 1994; 62(3):283-324. PubMed ID: 7972337
[TBL] [Abstract][Full Text] [Related]
12. The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.
van Zwieten PA; Blauw GJ; van Brummelen P
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):69S-74S. PubMed ID: 2268509
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]